Inhibikase Therapeutics Inc (NQ: IKT )
1.490
-0.100
(-6.29%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 18, 2024
Add to My Watchlist
Headline News about Inhibikase Therapeutics Inc![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
Topics
Product Recall
![]() Via Benzinga
Exposures
Product Safety
![]() ![]() Via Benzinga
![]()
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
June 18, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Stocks Muted Ahead of Big Fed Announcement
June 16, 2021
Via Talk Markets
Topics
Economy
Exposures
Interest Rates
![]() ![]() ![]() ![]()
Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences
June 16, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|